PRIOR PRINTER'S NOS. 775, 993
PRINTER'S NO. 1850
THE GENERAL ASSEMBLY OF PENNSYLVANIA
SENATE BILL
No.
655
Session of
2017
INTRODUCED BY YAW, McGARRIGLE, BAKER, ALLOWAY, ARGALL,
BARTOLOTTA, RESCHENTHALER, VULAKOVICH, LANGERHOLC, WHITE,
COSTA, MENSCH, KILLION, RAFFERTY, YUDICHAK, BROWNE, BREWSTER,
HUGHES, STEFANO, SCARNATI, SCAVELLO AND HAYWOOD, MAY 2, 2017
AS AMENDED ON THIRD CONSIDERATION, JUNE 11, 2018
AN ACT
Amending the act of April 14, 1972 (P.L.233, No.64), entitled
"An act relating to the manufacture, sale and possession of
controlled substances, other drugs, devices and cosmetics;
conferring powers on the courts and the secretary and
Department of Health, and a newly created Pennsylvania Drug,
Device and Cosmetic Board; establishing schedules of
controlled substances; providing penalties; requiring
registration of persons engaged in the drug trade and for the
revocation or suspension of certain licenses and
registrations; and repealing an act," further providing for
definitions, providing for Pennsylvania Safe and Effective
Opioid Prescribing Advisory Council and further providing for
promulgation of regulations.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Section 2(b) of the act of April 14, 1972
(P.L.233, No.64), known as The Controlled Substance, Drug,
Device and Cosmetic Act, is amended by adding a definition to
read:
Section 2. Definitions.--* * *
(b) As used in this act:
* * *
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22